Quantum-Si incorporated ( QSI) Stock. Should you Buy or Sell? $ 3.30
0.02 (0.60 %)
Quantum-Si incorporated Analysis
Updated on 10-09-2022| Symbol | QSI |
| Price | $3.30 |
| Beta | 0.000 |
| Volume Avg. | $1 M |
| Market Cap | $458.5 M |
| 52 Week Range | $2.22 - $9.365 |
Quantum-Si incorporated opened the day at $3.30 which is +'0.60 % on yesterday's close. Quantum-Si incorporated has a 52 week high of $9.365 and 52 week low of $2.22, which is a difference of $7.145. We like to see positive, upward trending shares, preferably with momentum. Market capitalization is $458.5 M and total net profit is $0 which means the company is trading at inf times profit to market capitalization. Theoretically, if you were to buy Quantum-Si incorporated for $458.5 M, it would take 15 years to get your money back. Quantum-Si incorporated are in the Biotechnology space which will have a sweet spot and industry standard for net profit multiples.
Price Chart
Financials
Quantum-Si incorporated Stock Forecast - Is Quantum-Si incorporated a Buy or Sell?
| DCF Score | Strong Buy | |
| ROE Score | Neutral | |
| ROA Score | Neutral | |
| DE Score | Neutral | |
| PE Score | Sell | |
| PB Score | Buy | |
| Overall Recommendation | Buy |
Growth and Value
| PE Ratio | 6.346 |
| Dividend Yiel | 0.000 |
| Net Profit Margin | 0.000 |
Valuing Quantum-Si incorporated
| Price Book Value Ratio | 1.109 | Price To Book Ratio | 1.109 |
| Price To Sales Ratio | 0.000 | Price Earnings Ratio | -3.985 |
How liquid is Quantum-Si incorporated
| Current Ratio | 35.436 |
| Quick Ratio | 35.048 |
Debt
| Debt Ratio | 0.067 | Debt Equity Ratio | 0.072 |
| Long Term Debt To Capitalization | 0.037 | Total Debt To Capitalization | 0.040 |
Latest news about Quantum-Si incorporated
GUILFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Participate in the Morgan Stanley 20th Annual Global Healthcare Conference
Quantum-Si incorporated (NASDAQ:QSI ) Q2 2022 Earnings Conference Call August 8, 2022 4:30 PM ET Company Participants Juan Avendano - Head, Investor Relations Jonathan Rothberg - Interim Chief Executive Officer Patrick Schneider - President and Chief Operating Officer Claudia Drayton - Chief Financial Officer Conference Call Participants Alex Vukasin - Canaccord Operator Ladies and gentlemen, thank you for standing by and welcome to the Quantum-Si Second Quarter 2022 Earnings Call. [Operator Instructions] Please be advised that today's conference is being recorded.
GUILFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Report Second Quarter 2022 Financial Results on August 8, 2022
GUILFORD, Conn.--(BUSINESS WIRE)--May 17, 2022--Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), a life sciences company commercializing single molecule protein sequencing, today announced that it will be participating in the Next-Generation Protein Analysis and Detection Conference, a VIB Tools & Technologies conference, taking place in Ghent, Belgium on May 30-31, 2022. Brian Reed, Ph.D., Head of Research, will provide an update on the Company's research and d
Quantum-Si incorporated (NASDAQ:QSI ) Q1 2022 Earnings Conference Call May 9, 2022 4:30 PM ET Company Participants Juan Avendano - Head, IR Jonathan Rothberg - Interim CEO Claudia Drayton - CFO Patrick Schneider - President and Chief Operating Officer Conference Call Participants Kyle Mikson - Canaccord Genuity Operator Ladies and gentlemen, thank you for standing by, and welcome to the Quantum-Si First 2022 Earnings Call. [Operator Instructions] Please be advised today's conference is being recorded.
About Quantum-Si incorporated
Description :
Quantum-Si incorporated, a life sciences company, develops a single molecule detection platform for sample preparation and sequencing. It offers a proprietary single molecule detection platform for use in semiconductor industry to field proteomics to enable next generation protein sequencing. The company was incorporated in 2013 is based in Guilford, Connecticut.
